Evolution Metals & Technologies Corp. Refutes Falsehoods in Capybara Research Short-Seller Report
Evolution Metals & Technologies Corp. (EMAT) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 Evolution Metals & Technologies Corp. Refutes Falsehoods in Capybara Research Short-Seller Report Company categorically refutes, in their entirety, the claims made in the Capybara Report dated November 16, 2026 and addresses each of them below MIAMI, FL, November 17,
How this was made
The 30-second read
Why it matters
EMAT’s 8-K attempts to neutralize reputational and valuation damage by denying each allegation and pointing to PCAOB-audited/reviewed financial statements and revenue-producing operations in Korea, while stating it is evaluating outside counsel to pursue claims.
Market read
This is a same-day, company-specific rebuttal that can influence near-term sentiment and volatility for EMAT, but it does not provide a definitive resolution.
What to watch
Traders may focus less on the rebuttal’s assertions and more on whether Capybara or third parties respond, whether regulators get involved, and whether EMAT’s cited filings fully address the specific disputed points.
Background
EMAT responds to a Capybara Research short-seller report published Nov. 16, 2026, alleging payoffs, criminal ties, insider trading, market manipulation, and lack of material operations.
Ticker impact
EMAT files an 8-K Regulation FD disclosure refuting Capybara Research’s claims and cites its Korea operations and recent revenue figures.
Likely choppy trading as the market weighs the company’s rebuttal versus the possibility of follow-on scrutiny or legal action.
The disclosure is company-specific and time-stamped, but it does not announce a settlement, new contract, or definitive legal outcome. It does, however, address multiple allegation categories and points to revenue-producing operations and filed financials.
Market effects
Highlights heightened risk for small-cap critical-materials issuers facing short-and-distort style campaigns, potentially increasing scrutiny of disclosures and operations claims.
No clear regional market mechanism beyond EMAT’s own Korea operations description.
Limited, as the dispute is company-specific and tied to US-listed trading and SEC disclosure.
Counterpoint
The rebuttal may not change fundamentals if the market views the allegations as credible enough to sustain valuation pressure until any legal or investigative process concludes.
Key entities
- companyEvolution Metals & Technologies Corp.
Nasdaq-listed critical materials and advanced manufacturing company that filed the Regulation FD 8-K rebutting Capybara Research.
- counterpartyCapybara Research
Short-seller whose Nov. 16 report EMAT disputes and says it is evaluating legal action against.
- personIgor Appelboom
Principal operator of Capybara Research, identified by EMAT as a target of potential legal claims.

